Medical Device

Predictive Technology Group (OTCPINK:PRED) announces that Predictive Therapeutics, its wholly-owned subsidiary, completed a crucial milestone in the development and commercialization of ARTGuide™. As quoted in the press release: Predictive Therapeutics, LLC anticipates its launch of a novel test for women experiencing infertility, as a result of endometriosis and other health concerns, called ARTGuide™.  The test is expected to change …

Predictive Technology Group (OTCPINK:PRED) announces that Predictive Therapeutics, its wholly-owned subsidiary, completed a crucial milestone in the development and commercialization of ARTGuide™.

As quoted in the press release:

Predictive Therapeutics, LLC anticipates its launch of a novel test for women experiencing infertility, as a result of endometriosis and other health concerns, called ARTGuide™. The test is expected to change the way Advanced Reproductive Technologies (ART), such as In Vitro Fertilization (IVF), are used to help couples struggling to have a baby. After testing thousands of women as part of the development program, the Company now expects commercial launch of the ARTGuide™ infertility test in the United States during Q3 2018.

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20621.39-436.79
TSXV856.62-33.73
DOW34265.37-450.02
S&P 5004397.94-84.79
NASD13768.92-385.10
ASX7175.80-166.60

COMMODITIES

Commodities
Gold1838.54+4.34
Silver24.16-0.11
Copper4.47-0.05
Palladium2115.50+18.50
Platinum1036.50+6.50
Oil85.70+0.56
Heating Oil2.65+0.02
Natural Gas3.91-0.09

DOWNLOAD FREE REPORTS

×